Clínica Médica
Revisão | Avaliação diagnóstica dos distúrbios motores e sensoriais gástricos.
21 Jan, 2022 | 15:40hDiagnostic Evaluation of Gastric Motor and Sensory Disorders – American Journal of Gastroenterology
M-A | Não há diferença nos desfechos com monoterapia com betalactâmico vs. terapia combinada nas infecções de corrente sanguínea ou pneumonia por P. aeruginosa.
21 Jan, 2022 | 15:37hBeta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to P. aeruginosa: a meta-analysis – International Journal of Antimicrobial Agents (link para o resumo – $ para o texto completo)
Estudo randomizado por cluster | Um programa multifatorial para prevenção de quedas nas casas de repouso do Reino Unido reduziu os índices de queda entre idosos e foi custo-efetivo.
21 Jan, 2022 | 15:23hComunicado de imprensa: Falls in care homes can be significantly reduced with intervention, says new study – University of Nottingham
Comentário no Twitter
NEW RESEARCH: A falls prevention programme for older people in care homes, co-designed with care home staff & residents, that involved awareness raising, education, screening, decision & implementation support was associated with a reduction in falls rate https://t.co/wupI0LeAxj
— The BMJ (@bmj_latest) December 11, 2021
Longevidade do reforço: dados revelam quanto tempo dura a proteção da terceira dose.
20 Jan, 2022 | 23:19hBooster longevity: Data reveals how long a third shot protects – NPR
Relatório original: SARS-CoV-2 variants of concern and variants under investigation in England – U.K. Health Security Agency
Estudo de coorte retrospectiva de base populacional no Catar mostrou menor risco de infecção por Covid-19 após a vacina da Moderna em comparação com a da Pfizer–BioNTech.
20 Jan, 2022 | 23:17hEffectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar – New England Journal of Medicine
Comentário no Twitter
In two matched retrospective cohort studies comparing BNT162b2 and mRNA-1273, both were highly effective at preventing hospitalization & death. Breakthrough infections were lower among those who received mRNA-1273 than those who received BNT162b2. https://t.co/wgkrzfLNHz pic.twitter.com/E8hXIDFqWW
— NEJM (@NEJM) January 19, 2022
Doença mais leve com a Ômicron: é o vírus ou é a imunidade pré-existente?
20 Jan, 2022 | 23:16hRevisão breve | Fluvoxamina para pacientes ambulatoriais sintomáticos com COVID-19.
20 Jan, 2022 | 23:12hFluvoxamine for symptomatic outpatients with COVID-19 – Canadian Medical Association Journal
Conteúdos relacionados:
Fluvoxamine for Covid-19: What Prescribers and Pharmacists Need to Know.
Fluvoxamine for the early treatment of SARS-CoV-2 Infection: a review of current evidence.
Análise sistemática | Impacto global da resistência bacteriana a antibióticos em 2019.
20 Jan, 2022 | 23:06hGlobal burden of bacterial antimicrobial resistance in 2019: a systematic analysis – The Lancet
Comunicado de imprensa: An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria – The Lancet
Editorial: Antimicrobial resistance: time to repurpose the Global Fund – The Lancet
Comentário: Antimicrobial resistance now a leading cause of death worldwide, study finds – The Guardian
Comentário no Twitter
NEW—An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria.#GRAMPaper reveals the scale of antimicrobial resistance (#AMR), now a leading cause of death worldwide: https://t.co/2h5UEKemEq #AMRSOS pic.twitter.com/aWLhmdirJ8
— The Lancet (@TheLancet) January 20, 2022
Estudo randomizado | Entre pacientes com infecção recorrente por Clostridioides difficile, o uso de SER-109, uma terapia de microbioma oral, reduziu a taxa de recorrência em comparação ao placebo (12% vs. 40%).
20 Jan, 2022 | 23:02hSER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection – New England Journal of Medicine (link para o resumo – $ para o texto completo)